This is an exciting opportunity to join a high growth digital media company, which has both online publications and a content consultancy, working in healthcare, contributing daily writing news art
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS